{"url_path":"/sec/krro/8-k/2026-06-11/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-11","source_url":"https://www.sec.gov/Archives/edgar/data/1703647/0001193125-26-267741-index.html","accession_number":"0001193125-26-267741","cik":"0001703647","ticker":"KRRO","issuer_name":"Korro Bio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1703647/0001193125-26-267741-index.html","primary_entity_key":"0001703647","primary_entity_name":"Korro Bio, Inc."},"word_count":290,"has_tables":true,"body_markdown":"Item 5.07. Submission of Matters to a Vote of Security Holders.\n\nThe following is a summary of the matters voted on at the 2026 annual meeting of stockholders of Korro Bio, Inc., or Korro, held on June 10, 2026, or the Annual Meeting.\n\n1)\nKorro’s stockholders elected each of Nessan Bermingham and Rachel Meyers as Class I directors, each for a three-year term ending at the annual meeting of stockholders to be held in 2029 and each until his or her respective successor has been duly elected and qualified or until his or her earlier death, resignation or removal. The results of the stockholders’ vote with respect to the election of the two Class I directors are as follows:\n\n \n\nName\n\n \n\nVotes\nFor\n\n \n\nVotes\nWithheld\n\n \n\nBroker\nNon-Votes\n\nNessan Bermingham\n\n \n\n7,468,003\n\n \n\n1,576,660\n\n \n\n1,875,955\n\nRachel Meyers\n\n \n\n7,368,284\n\n \n\n1,676,379\n\n \n\n1,875,955\n\n \n\n2)\nKorro’s stockholders approved, in a non-binding, advisory vote, the compensation of Korro’s named executive officers. The results of the stockholders’ advisory vote with respect to the compensation of Korro’s named executive officers are as follows:\n\n \n\nVotes\nFor\n\n \n\nVotes\nAgainst\n\n \n\nAbstain\n\n \n\nBroker\nNon-Votes\n\n9,009,739\n\n \n\n27,988\n\n \n\n6,936\n\n \n\n1,875,955\n\n \n\n3)\nKorro’s stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2026. The results of the stockholders’ vote with respect to such ratification are as follows:\n\n \n\nVotes\nFor\n\n \n\nVotes\nAgainst\n\n \n\nAbstain\n\n \n\nBroker\nNon-Votes\n\n10,917,621\n\n \n\n2,738\n\n \n\n259\n\n \n\n0\n\n \n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\nKORRO BIO, INC.\n\n \n\n \n\nDate: June 11, 2026\n\nBy:\n\n/s/ Ram Aiyar\n\n \n\n \n\n \n\n \n\n \n\nName: Ram Aiyar\n\n \n\n \n\nTitle: President and Chief Executive Officer and Interim Chief Financial Officer"}